co-infection

Documents about co-infection

• Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children#152474ClinicalTrials.gov
• Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)#343701ClinicalTrials.gov
• Medical Implications of Coinfection With Malaria and Filariasis Parasites#870851ClinicalTrials.gov
• Natural viral co-infections in pig herds affect hepatitis e virus (hev) infection dynamics and increase the risk of contaminated livers at slaughter#7826HAL (France)
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection#864996ClinicalTrials.gov
• Histopathological Features and p16/p62 Expression as Indicators of High-Risk HPV Co-Infection in Anogenital Condyloma Acuminata.#135974NCBI PubMed Central
• Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster#325156ClinicalTrials.gov
• Bayesian shared-component spatiotemporal modeling of sexually transmitted infection co-occurrence: identifying geographic vulnerability across 204 countries, 1990-2023#467688bioRxiv / medRxiv
• P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales#256910ClinicalTrials.gov
• Predicting frequency distribution and influence of sociodemographic and behavioral risk factors of Schistosoma mansoni infection and analysis of co-infection with intestinal parasites#345457Repositório Institucional da Universidade Federal de Sergipe
• Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates#842686ClinicalTrials.gov
• Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection#852298ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection#879759ClinicalTrials.gov
• Systemic inflammation and malaria co-infection in irritable bowel syndrome: a cross-sectional study of 142 Yemeni patients.#162192NCBI PubMed Central
• Herpes Viral Co-Infection in Benign Mooren’s Ulcer#922301Figshare
• "Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"#1010851ClinicalTrials.gov
• Modélisation des dynamiques de co-infections entre virus respiratoires dans l’épithélium respiratoire humain reconstitué#235168HAL (France)
• Global, Regional, and National Burden of HIV and Drug-Susceptible Tuberculosis Co-Infection Among Adolescents and Young Adults (1990-2021).#196099NCBI PubMed Central
• A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults#261334ClinicalTrials.gov
• Preserved CD4+ T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy#341946bioRxiv / medRxiv
• First Report of Mycobacterium bovis and Nocardia spp. Co-Infection in a Roan Antelope#344732IRIS
• Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old#967361ClinicalTrials.gov
• Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection#1033087ClinicalTrials.gov
• Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics#898772ClinicalTrials.gov
• Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older#146287ClinicalTrials.gov
• A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection#837020ClinicalTrials.gov
• Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)#898226ClinicalTrials.gov
• HIV/AIDS Infection in Madagascar : genetic diversity, antiretroviral resistance, and viral co-infections.#1038975HAL (France)
• A Global Perspective on the Emerging Threat of Zika and Dengue Co-infection#143898PLOS
• Co-infection restrains Litomosoides sigmodontis filarial load and plasmodial P. yoelii but not P. chabaudi parasitaemia in mice#208031Zenodo (CERN)
• To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects#253031ClinicalTrials.gov
• HPV co-infection burden, vaginal microbiota restructuring, and host context are associated with Cervical precancer risk in a racially restricted observational cohort#279372bioRxiv / medRxiv
• A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection#387190ClinicalTrials.gov
• The root-knot nematode effector Mi1D08B targets a NINJA-family co-repressor to suppress jasmonate production and promote infection in soybean.#481065NCBI PubMed Central
• Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori#827146ClinicalTrials.gov
• Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients#848092ClinicalTrials.gov
• Pharmacist-led Hepatitis C Management#859889ClinicalTrials.gov
• Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections#876616ClinicalTrials.gov
• TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood#803141ClinicalTrials.gov
• A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection#851835ClinicalTrials.gov
• Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19#886046ClinicalTrials.gov
• Hepatitis B and HIV Co-Infection in Patients in Uganda#901476ClinicalTrials.gov
• A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients#909391ClinicalTrials.gov
• Evaluation of ceftiofur-PHBV microparticles in rats#935669Repositorio de Universidad Autónoma de Chile.
• Co-Existence of Urinary Tract Infection and Malaria Among children Under Five Years: A Case of Muhimbili National Hospital Dar es Salaam,Tanzania.#1023013The Open University of Tanzania Institutional Repository
• Management of Dermatology Conditions by Community Pharmacists: Evaluation of PATH-DERM - Final Report#395073Figshare
• HIV and Hepatitis B co-infection in Tanzania: Analysis of the 2022–2023 Tanzania HIV Impact Survey#686598PLOS
• A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More#895336ClinicalTrials.gov
• Overnutrition, Nasopharyngeal Pathogenic Bacteria and Proinflammatory Cytokines in Infants with Viral Lower Respiratory Tract Infections#936046Repositorio de Universidad Autónoma de Chile.
• Data for: "The epidemiology and clinical features of HIV and Trypanosoma cruzi (Chagas disease) co-infection: A systematic review and individual patient data analysis"#235504LSHTM Data Compass